You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor necrosis factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiac Functions in Type 1 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • transthoracic echocardiography
  • (no location specified)
Nov 12, 2023

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

Not yet recruiting
  • Pleural Effusion, Malignant
  • pleural markers
  • (no location specified)
Jan 20, 2023

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • Inflammation
  • (no location specified)
Nov 21, 2023

Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human

Recruiting
  • Peritoneal Metastases
  • Colorectal Cancer
  • Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Mar 2, 2023

Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

Completed
  • Arthritis Rheumatoid
  • New York, New York
    Pfizer
Jun 8, 2022

Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

Completed
  • Acute Graft-versus-host Disease
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 11, 2023

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 20, 2023

    Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

    Recruiting
    • Rheumatoid Arthritis
    • Exercise
    • No exercise
    • Copenhagen, Denmark
      Rigshospitalet
    Feb 3, 2022

    GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

    Completed
    • Periodontitis
    • Periodontal clinical measurements and GCF sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Dec 8, 2022

    COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,

    Not yet recruiting
    • COPD Exacerbation Acute
    • +2 more
    • Interleukin-1B
    • +4 more
    • (no location specified)
    Mar 23, 2023

    Periimplant Soft Tissue Phenotype on Marginal Bone Loss

    Completed
    • Alveolar Bone Loss
    • +2 more
    • Nuclear Factor-Kappa B Ligand (RANKL) analysis
    • +4 more
    • Konya, Turkey
      Necmettin Erbakan University, dentistry Faculty
    Jan 24, 2023

    Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

    Not yet recruiting
    • Rheumatoid Arthritis
    • Observation
    • (no location specified)
    Oct 8, 2022

    HIV Trial in Seattle (Tumor Necrosis Factor, Interferon gamma-1b)

    Completed
    • HIV Infections
    • Tumor Necrosis Factor
    • Interferon gamma-1b
    • Seattle, Washington
      Univ of Washington
    Oct 28, 2021

    Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

    Completed
    • Early Childhood Caries
    • ELISA
    • Aydın, Turkey
      Sultan KELEŞ
    Oct 20, 2021

    FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

    Recruiting
    • FSGS
    • +3 more
    • Ann Arbor, Michigan
    • +3 more
    Jan 31, 2022

    HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

    Completed
    • HIV Infections
    • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
    • Honolulu, Hawaii
    • +2 more
    Oct 28, 2021

    HIV Trial in Boston, Cleveland (Pentoxifylline)

    Completed
    • HIV Infections
    • Boston, Massachusetts
    • +1 more
    Oct 26, 2021

    Lung Cancer Trial (TILT-123, Pembrolizumab)

    Not yet recruiting
    • Lung Cancer
    • TILT-123
    • Pembrolizumab
    • (no location specified)
    Nov 5, 2023

    HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

    Recruiting
    • Drug Monitoring
    • Inflammatory Bowel Diseases
    • Tumor necrosis factor (TNF)-alpha inhibitors
    • Valladolid, Spain
      Hospital Universitario Rio Hortega
    Aug 8, 2023

    Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

    Not yet recruiting
    • Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset
    • +2 more
    • Measuring inflammatory serum biomarkers
    • (no location specified)
    Oct 4, 2022

    Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)

    Enrolling by invitation
    • Aneurysm
    • +3 more
    • San Francisco, California
      UCSF Medical Center
    Apr 25, 2022

    Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

    Active, not recruiting
    • Colitis,Ulcerative
    • Discontinuation of anti-TNF treatment
    • Continuation of anti-TNF treatment
    • Alesund, Norway
    • +18 more
    Jul 13, 2022